A detailed history of Man Group PLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Man Group PLC holds 474,093 shares of EXEL stock, worth $16.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
474,093
Previous 658,859 28.04%
Holding current value
$16.7 Million
Previous $15.6 Million 31.87%
% of portfolio
0.03%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$20.34 - $23.73 $3.76 Million - $4.38 Million
-184,766 Reduced 28.04%
474,093 $10.7 Million
Q1 2024

May 15, 2024

SELL
$20.17 - $23.93 $2.07 Million - $2.45 Million
-102,518 Reduced 13.46%
658,859 $15.6 Million
Q4 2023

Feb 14, 2024

BUY
$19.25 - $24.13 $4.2 Million - $5.26 Million
217,930 Added 40.1%
761,377 $18.3 Million
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $8.38 Million - $10 Million
440,342 Added 427.08%
543,447 $11.9 Million
Q2 2023

Aug 14, 2023

BUY
$18.17 - $20.48 $576,479 - $649,768
31,727 Added 44.45%
103,105 $1.97 Million
Q1 2023

May 15, 2023

SELL
$16.3 - $19.41 $13.4 Million - $16 Million
-823,901 Reduced 92.03%
71,378 $1.39 Million
Q4 2022

Feb 14, 2023

BUY
$14.96 - $17.39 $89,909 - $104,513
6,010 Added 0.68%
895,279 $14.4 Million
Q3 2022

Nov 14, 2022

SELL
$15.68 - $22.27 $1.77 Million - $2.51 Million
-112,873 Reduced 11.26%
889,269 $13.9 Million
Q2 2022

Aug 15, 2022

BUY
$17.44 - $23.16 $11.8 Million - $15.7 Million
678,485 Added 209.63%
1,002,142 $20.9 Million
Q1 2022

May 16, 2022

BUY
$17.03 - $22.67 $2.49 Million - $3.32 Million
146,314 Added 82.5%
323,657 $7.34 Million
Q4 2021

Feb 14, 2022

BUY
$15.84 - $21.88 $1.67 Million - $2.31 Million
105,462 Added 146.72%
177,343 $3.24 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $21.14 $736,450 - $955,126
45,181 Added 169.22%
71,881 $1.52 Million
Q2 2021

Aug 16, 2021

SELL
$17.95 - $25.56 $100,143 - $142,599
-5,579 Reduced 17.28%
26,700 $486,000
Q1 2021

May 17, 2021

BUY
$20.53 - $25.22 $128,784 - $158,205
6,273 Added 24.12%
32,279 $729,000
Q4 2020

Feb 16, 2021

SELL
$18.39 - $24.8 $7.04 Million - $9.49 Million
-382,602 Reduced 93.64%
26,006 $522,000
Q3 2020

Nov 16, 2020

SELL
$20.67 - $26.94 $683,556 - $890,905
-33,070 Reduced 7.49%
408,608 $9.99 Million
Q2 2020

Aug 14, 2020

SELL
$16.46 - $27.42 $853,549 - $1.42 Million
-51,856 Reduced 10.51%
441,678 $10.5 Million
Q1 2020

May 15, 2020

SELL
$14.46 - $21.8 $2.27 Million - $3.42 Million
-157,019 Reduced 24.14%
493,534 $8.5 Million
Q4 2019

Feb 18, 2020

BUY
$15.15 - $18.89 $3.46 Million - $4.31 Million
228,060 Added 53.98%
650,553 $11.5 Million
Q3 2019

Nov 14, 2019

BUY
$17.68 - $22.65 $4.7 Million - $6.02 Million
265,894 Added 169.79%
422,493 $7.47 Million
Q2 2019

Aug 14, 2019

BUY
$18.93 - $24.75 $1.96 Million - $2.56 Million
103,477 Added 194.79%
156,599 $3.35 Million
Q1 2019

May 15, 2019

BUY
$19.6 - $24.76 $156,290 - $197,436
7,974 Added 17.66%
53,122 $1.27 Million
Q4 2018

Feb 14, 2019

SELL
$13.65 - $21.8 $240,048 - $383,374
-17,586 Reduced 28.03%
45,148 $888,000
Q3 2018

Nov 14, 2018

BUY
$15.87 - $22.4 $546,737 - $771,702
34,451 Added 121.81%
62,734 $1.11 Million
Q2 2018

Aug 14, 2018

SELL
$18.56 - $22.45 $443,918 - $536,959
-23,918 Reduced 45.82%
28,283 $608,000
Q1 2018

May 15, 2018

BUY
$22.15 - $31.89 $1.16 Million - $1.66 Million
52,201 New
52,201 $1.16 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.3B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.